scholarly journals PDB7 ASSESSMENT OF CARDIOVASCULAR OUTCOMES ASSOCIATED WITH SODIUM GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITOR THERAPY AND INCRETIN-BASED THERAPIES AMONG ELDERLY PATIENTS TYPE 2 DIABETES MELLITUS

2020 ◽  
Vol 23 ◽  
pp. S108-S109
Author(s):  
S. Korgaonkar ◽  
Y. Yang ◽  
J. Pitcock ◽  
J. Sherman
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Elderly Patients ◽  
Sglt2 Inhibitor ◽  
Cardiovascular Outcomes ◽  
Inhibitor Therapy ◽  
Sodium Glucose Cotransporter

1127-P: Real-World Clinical Outcomes Associated with Canagliflozin 100mg and with Intensification of SGLT2 Inhibitor Therapy Switching to Canagliflozin 300mg in Patients with Type 2 Diabetes Mellitus: The Real-WECAN Study

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1127-P
Author(s):  
JUAN J. GORGOJO-MARTINEZ ◽  
MANUEL A. GARGALLO-FERNANDEZ ◽  
ALBA GALDON ◽  
TERESA ANTÓN-BRAVO ◽  
MIGUEL BRITO-SANFIEL ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Clinical Outcomes ◽  
Real World ◽  
Sglt2 Inhibitor ◽  
Inhibitor Therapy ◽  
The Real
Sign in / Sign up

Export Citation Format

Share Document